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Organ printing is an emerging technology that can potentially replace the need for human organ transplants altogether. 
Organ printing uses bioprinting methods to create three-dimensional biological constructs. Although it has not yet been 
implemented successfully, with nearly two decades of research devoted to this area, much progress has been made. This 
article outlines the various aspects of the organ printing process, describes both the accomplishments and challenges of 
bioprinting, and discusses the feasibility of bioprinting as a viable method for organ replacement.  
The Viability of Organ Printing  
Estie Schick  
Introduction 
 The cutting-edge principles of organ printing tech-
nology have been compared to the age-old properties of 
Johannes Guttenberg’s printing press (Mironov et. al., 
2008). The essential elements necessary for printing a 
book include a printing press, ink, paper, movable type, 
and a written text to be printed. These very same compo-
nents can be applied to the up-and-coming field of bi-
oprinting. Bioprinting is literally biological printing and uti-
lizes the technology of a bioprinter to build a three-
dimensional biological construct. This incredible feat is per-
formed by the printer placing cells, bioink, layer-by-layer in 
specific locations onto a biopaper suitable for sustaining 
cell life. Printing biomaterials is obviously much more com-
plex, but at its most basic levels it is analogous to the 
printing methods of a simple printing press. The necessary 
components for bioprinting are a bioprinter, bioink, biopa-
per, a method for depositing the biomaterials in set  
locations, and a model of the tissue or organ to be printed. 
 Organ printing technology has emerged as the top-
ic of much research and discussion because of the short-
age of organs for transplantation. There are other options 
besides for human organ donation such as xenotransplan-
tation as well as artificial or mechanical organs (Boland et. 
al., 2003). But these options are the source of deleterious 
side effects, causing many to look to bioprinting as the fu-
ture method for organ replacement. 
 That is not to say that there are not many road-
blocks in the way of organ printing. The entire idea of 3D 
printing is somewhat reminiscent of science fiction and 
that is even before live human organs enter the picture. 
Because this is such a new field of study, there has not yet 
been much success in actually printing an organ. There are 
important steps and milestones that must be met along 
the way. In fact, there is no hope of an organ being printed 
successfully before tissue can be printed flawlessly. And 
there is certainly a long way to go before organs will be 
printed on an industrial scale. So it is important to ask: will  
bioprinting be a viable method for replacing damaged  
organs? 
Materials and Methods 
 In order to answer the question proposed above, 
many journal articles relating to this topic have been read. 
Touro College’s library database was also used to search 
for relevant studies and reviews. The next step taken was 
to look for articles that were referenced by those obtained 
through the Touro College Library search engines that 
seemed pertinent. All of the articles accumulated through 
this research have been used in an attempt to conclusively 
answer the question of the viability of organ printing. 
Results 
The Basics of Bioprinting: Bioprinters 
 Bioprinting uses computer-aided printing technol-
ogy to deposit cells layer-by-layer in specific locations and 
form three-dimensional biological constructs. Many factors 
play a part in determining the efficacy of the bioprinting 
method, and a major one is the bioprinter. A decade ago, 
one of the first studies detailing the transformation of an 
ordinary commercial inkjet printer into a bioprinter was 
published. Inkjet printing was chosen specifically because 
the cells in the bioink were kept more hydrated than could 
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be obtained using any other printing method. In addition, 
inkjet printers are a significantly more economical choice 
than a more complex 3D printer. Inkjet printers are able to 
deposit tiny ink drops onto a substrate upon demand using 
thermal inkjet technology (Wilson, Boland, 2003). A small 
air bubble is heated until it expands and then collapses. 
When it collapses, that air bubble serves as the pressure 
pulse that forces a very tiny droplet of bioink out of the 
nozzle. The temperature can reach as high as 300° C, but 
the entire process is so instantaneous that pulse lasts only 
a couple of microseconds. Consequently the heightened 
temperatures do not permeate the bioink, and living cells 
can thereby be printed. With the advantage of inkjet based 
bioprinting, living cells can be printed at the same time as 
nutrients, drugs and growth factors, as well as gels and 
scaffolds (Cui, Boland, 2009). 
 Multiple printers were studied and each one was 
optimized for a specific application. The Cannon BJ2200 
printer was modified so that cells could be printed onto 
very thin samples- as thin as 1 mm. Temperature controls 
were also added so that none of the living cell samples 
could be denatured by a heat above 100° F. The printer 
software drivers of an HP 550C were adapted so that solu-
tions with different electrical charges and different viscosi-
ties could be printed. In order for pH, charge and viscosity 
of the cell sample not to affect the printing, new software 
was written that adjusts voltages constantly. Using the de-
signs for the HP 660C printer, a new printer was built with 
a base that allowed for height adjustment. Consequently, 
the printed samples could be moved along the x and y 
planes. That same printer was further modified so that 
large mammalian cells could be printed. It would be im-
possible for cells of this size to fit through the nozzle of a 
regular inkjet printer so modifications had to be made to 
the print head. The new print head is made of nine individ-
ual pumps which can be operated individually, allowing 
multiple cells types to be printed onto the same sample. 
The nine pumps can be used simultaneously or a specific 
pump can be programmed to deposit cells at a given time. 
New software has been created that allows someone to 
simply enter the instructions on the computer and then 
watch the printer carry out those directions (Wilson, Bo-
land, 2003). 
 In contrast to the inkjet printing method, laser as-
sisted bioprinting has also emerged as a viable bioprinting 
technique. The Laser Induced Forward Transfer (LIFT) was 
originally used as a mechanism for transferring metals. It 
has been applied to bioprinting, resulting in a bioprinter 
named LaBP, the laser-assisted biological printer. This 
printer deposits suspended cell material onto a thin metal 
ribbon which is then hit with a laser pulse. The liquid solu-
tion is thereby deposited onto a sample of biopaper. In a 
recent study, factors such as cell density, viscosity, laser 
printing speed and laser energy were optimized to result in 
cell printing with the highest resolution. Rabbit carcinoma 
cells and human umbilical vein endothelial cells were used 
as bioink and suspended in liquid form. Different suspen-
sions were prepared and their respective viscosities were 
measured. A correlation was drawn between high cell vis-
cosity and a small droplet diameter which yields a high 
printing resolution. Different laser intensities and various 
laser speeds were tested as well. Decreased laser energy 
droplets and high laser scanning speeds resulted in high 
cell printing resolution. This study demonstrated that laser 
assisted bioprinting could successfully print biological 
structures, and a high cell-level resolution can be obtained. 
One advantage that laser-assisted bioprinting holds over 
inkjet bioprinting is the ability to print a high volume of 
cells per droplet. This is possible because the LaBP can 
print cells from a bioink with a concentration as high as 
108 cells/ml. Using inkjet printing technology, there is a 
concern with using high concentration bioink because the 
printer head can clog. This is not an issue with laser-
assisted bioprinting, and as a result high concentrations of 
cells can be used and cells can be still be printed one by 
one. The authors suggest further studies that implement a 
cell recognition scanning technology, which would help 
ensure that only one cell is being deposited with each laser 
pulse (Guillotin et. al., 2010). 
The Basics of Bioprinting: Biopaper 
 Cell printing necessitates the use of biopaper so 
that the cells can be hydrated after printing. The drying 
process of the ink will have an effect on cell survival, and 
therefore the materials used as biopaper are imperative to 
the bioprinting process (Xu et. al., 2006). Therefore, in an 
innovative study, hydrogels are well suited to act as biopa-
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per. The bioprinter that was used in the study was modi-
fied so that multiple types of hydrogel with or without cell 
suspensions can be printed into patterns. A correlation was 
drawn between certain printer control settings and the 
width of the printed hydrogel pattern. For example, the 
nozzle velocity, nozzle diameter and flow rate all have an 
effect on the hydrogel patterns. The specific hydrogel used 
in this study was formed by cross-linking hyaluronic acid 
with polyethylene glycol. This hydrogel (without cell sus-
pensions) was printed multiple times, each time with var-
ied printer settings. These tests yielded pattern widths 
ranging from 603.218 µm down to 141.38 µm. In all experi-
ments, the temperature and humidity levels were con-
trolled. Printing speed, nozzle diameter and injection 
speed were all varied, and a narrow hydrogel pattern width 
(i.e. 141.38 µm) was obtained with a fast printing speed, 
slow flow rate, and most importantly, small needle diame-
ter (Song et. al., 2010). 
 In a groundbreaking study, a cell printer success-
fully printed nine cell types into a 3D construct using ther-
mo-reversible gels. These gels are well-suited to become 
the biopaper in a printed tissue or organ because of their 
unique qualities. The gels are biodegradable, nontoxic and 
thermo-reversible, meaning that they are in a gel state at 
temperatures above 32° C and in a liquid state at tempera-
tures below 20° C. The authors theorized that by dropping 
a layer of gel onto a heated substrate, printing cell aggre-
gates onto that biopaper and repeating that process, 3D 
constructs would be formed as the cell aggregates fused 
together. In order to successfully perform that experiment, 
the optimal gel thickness and cell aggregate size had to be 
determined. 
 Both thermosensitive gels and collagen gels were 
prepared and their minimal thicknesses were measured. 
The reasons for using both types of gels in the 3D con-
struct are to provide stability and strength, as well as form-
ing a ‘drug-delivery service.’ This allows certain growth fac-
tors and bioactive agents to be released throughout the 
construct in a controlled fashion. The specific advantage of 
thermosensitive gels is that the time it takes for the gel to 
form directly affects the distribution of cells within the gel. 
Therefore, using gels that respond to temperature which 
gel more quickly than gelation controlled by solvent, pH, or 
ionic cross linking proves to be beneficial. Cell aggregates 
were also prepared using bovine aortal endothelial cells. 
The cells were printed onto series of gel layers. The cells 
were suspended in a liquid solution and did not spread out 
once they were printed on the gel layers. In addition, there 
was little, if any, mingling of the gel layers. But in order for 
this method to successfully form 3D tissue, fusion needs to 
occur between the cell aggregates. Although fusion of cell 
aggregates appeared to be more effective in collagen gels 
than in thermo-reversible gels, fusion did occur in those 
gels as well. Furthermore, it was demonstrated that fusion 
was not limited to the cells in the top layer of gel, but it 
was equally prevalent within the many layers of gel. In ad-
dition, a live/dead assay was performed, and showed that 
while cells that were not spread throughout the gels un-
derwent cell death, the cells within the gels were remained 
alive. According to the authors, the adhesiveness of gels 
for cells is a property that can be modified, so the lower 
rate of diffusion through thermosensitive gels is not so 
worrisome. The aspect of the experiment that is slightly 
problematic is the small amount of apoptosis and necrosis 
that occurred as a result of cells being printed. The authors 
suggest further studies using aggregates modified with 
additional survival factors or genetic antiapoptotic modifi-
cations. Though there can be many changes made that will 
improve the results of this study, it demonstrated that by 
using thermo-reversible gels as biopaper, 3D organ printing 
is feasible (Boland et. al., 2003). 
The Basics of Bioprinting: Bioink 
 The physical properties of sodium alginate hydro-
gel cross-linked with calcium chloride were examined in a 
study that found it well-suited to behave as bioink. Sodium 
alginate hydrogel has the unique property of fast gelation 
at room temperature because it solidifies upon contact 
with calcium chloride, making it a prime candidate for bi-
oprinting. Because of the ionic cross-link controlled gela-
tion, and because cells and growth factors can easily be 
suspended within the sodium alginate hydrogel, it makes 
an effective bioink. A multinozzle printing system was used, 
allowing the speed of gel injection to be controlled. The 
bioprinter used in this study was modified with a multi-
nozzle injection syringes, as well as the ability to control 




nate structure was printed using a four-nozzle system. 
Each gel layer was composed of a sodium alginate solution 
followed by a calcium chloride solution printed in the 
pattern of a lattice structure. 
 A ‘layered pattern accumulation test’ was per-
formed to determine whether the sodium alginate-calcium 
chloride gel could be used to create 3D tissue constructs. 
The gels were printed using the multinozzle printer into a 
lattice pattern. The pattern held successfully, although it 
acquired a sideways slant due to the viscosity of sodium 
alginate hydrogel. This caused each layer to drag on the 
layer immediately below it. In future studies that problem 
should be rectified by using creating a system that will con-
trol the gel hardness and solidification time. Despite this 
setback, the feasibility of using cells suspended in sodium 
alginate hydrogel to print 3D biological constructs was 
clearly demonstrated by this study (Song et. al.,  2011). 
Bioprinting vs. Scaffold-Based Tissue Engineering 
 Tissue engineering is a field that combines biology, 
chemistry, physics and engineering in order to create or 
repair biological tissue. Because of the complexities in the 
structure and mechanics of biological tissue, there are ob-
viously many challenges in the creation of tissue that per-
forms and functions exactly the way it should. Nonethe-
less, for years tissue engineering has been incredibly suc-
cessful. Popular uses of tissue engineering are to repair or 
replace body tissue including skin, muscle, bone, and blood 
vessels. 
 Typically, living cells are used as the primary engi-
neering material in tissue engineering. These cells are 
placed or ‘seeded’ into a 3D artificial rigid structure- a 
scaffold. Scaffolding allows many of the challenges of tis-
sue engineering to be overcome. For example, by using a 
solid structure like a scaffold, the implanted cells can 
attach onto its surfaces and eventually are able to form 
into three-dimensional tissues. One difficulty in creating 
scaffolds is that they need to be structured in a way that 
encourages optimal tissue formation to occur. This dictates 
what material the scaffold will be constructed from (i.e. 
how porous the material is.) This is important so that the 
nutrients can diffuse easily through the scaffold and reach 
the cells as necessary (Chan, Leong, 2008). The scaffolding 
material should also be biodegradable so that the scaffold 
will not have to be removed surgically. Instead, the 
scaffold needs to provide support to the cells while they 
are still forming their own structures, and then become 
absorbed by them when the three-dimensional tissue is 
fully formed. Additional factors that are important in 
scaffold-based tissue engineering are immunogenicity, the 
toxicity of the scaffolding material, and inflammatory re-
sponse by the host (Norotte et. al., 2009). 
 There are cases when the use of scaffolds in tissue 
engineering proves detrimental to the newly forming tis-
sue. Scaffolds can reduce the amount of connection be-
tween cells and can cause the misalignment of extracellu-
lar matrix.  Additionally, it is difficult to place the many 
different types of cells usually found in an organ in specific 
locations in a solid scaffold. Another major problem with 
scaffolding is that it is not yet possible for vascular tissue to 
be formed, resulting in the absence of vascularization in 
any scaffold-based engineered tissue (Boland et. al. 2003). 
For these reasons and more, other scaffold- free tissue 
engineering options have been explored.   
 Bioprinting uses 3D printing technology to print 
cells layer-by-layer and create biological materials, and is 
an example of scaffold-free tissue engineering. One of the 
largest roadblocks in the success of scaffold-based tissue 
engineering was the inability to create vascular structures. 
In 2009, vascular tissue was successfully engineered using 
scaffold-free bioprinting. In this study, a rapid prototyping 
technology was developed which instructed a bioprinter to 
deposit bioink onto biopaper. More specifically, multicellu-
lar tissue spheroids of Chinese hamster ovary cells, human 
skin fibroblast cells, and human umbilical vein smooth 
muscle cells were used as bioink. In addition, agarose rods 
were used to build a template for the tubular vascular 
structure. These materials were placed layer by layer onto 
a biopaper made of collagen gel using a bioprinter that 
was designed with two printing heads. This allowed the 
simultaneous placement of the multicellular spheroids as 
well as the agarose rods. The use of the agarose rods as a 
template allowed the diameter of the tubular structure, 
the wall thickness, and the branching pattern of the vascu-
lature to be accurately controlled. Once the spheroids 
were all deposited in the correct locations, their fusion was 
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followed by a calcium chloride solution printed in the 
pattern of a lattice structure. 
 A ‘layered pattern accumulation test’ was per-
formed to determine whether the sodium alginate-calcium 
chloride gel could be used to create 3D tissue constructs. 
The gels were printed using the multinozzle printer into a 
lattice pattern. The pattern held successfully, although it 
acquired a sideways slant due to the viscosity of sodium 
alginate hydrogel. This caused each layer to drag on the 
layer immediately below it. In future studies that problem 
should be rectified by using creating a system that will con-
trol the gel hardness and solidification time. Despite this 
setback, the feasibility of using cells suspended in sodium 
alginate hydrogel to print 3D biological constructs was 
clearly demonstrated by this study (Song et. al.,  2011). 
Bioprinting vs. Scaffold-Based Tissue Engineering 
 Tissue engineering is a field that combines biology, 
chemistry, physics and engineering in order to create or 
repair biological tissue. Because of the complexities in the 
structure and mechanics of biological tissue, there are ob-
viously many challenges in the creation of tissue that per-
forms and functions exactly the way it should. Nonethe-
less, for years tissue engineering has been incredibly suc-
cessful. Popular uses of tissue engineering are to repair or 
replace body tissue including skin, muscle, bone, and blood 
vessels. 
 Typically, living cells are used as the primary engi-
neering material in tissue engineering. These cells are 
placed or ‘seeded’ into a 3D artificial rigid structure- a 
scaffold. Scaffolding allows many of the challenges of tis-
sue engineering to be overcome. For example, by using a 
solid structure like a scaffold, the implanted cells can 
attach onto its surfaces and eventually are able to form 
into three-dimensional tissues. One difficulty in creating 
scaffolds is that they need to be structured in a way that 
encourages optimal tissue formation to occur. This dictates 
what material the scaffold will be constructed from (i.e. 
how porous the material is.) This is important so that the 
nutrients can diffuse easily through the scaffold and reach 
the cells as necessary (Chan, Leong, 2008). The scaffolding 
material should also be biodegradable so that the scaffold 
will not have to be removed surgically. Instead, the 
scaffold needs to provide support to the cells while they 
are still forming their own structures, and then become 
absorbed by them when the three-dimensional tissue is 
fully formed. Additional factors that are important in 
scaffold-based tissue engineering are immunogenicity, the 
toxicity of the scaffolding material, and inflammatory re-
sponse by the host (Norotte et. al., 2009). 
 There are cases when the use of scaffolds in tissue 
engineering proves detrimental to the newly forming tis-
sue. Scaffolds can reduce the amount of connection be-
tween cells and can cause the misalignment of extracellu-
lar matrix.  Additionally, it is difficult to place the many 
different types of cells usually found in an organ in specific 
locations in a solid scaffold. Another major problem with 
scaffolding is that it is not yet possible for vascular tissue to 
be formed, resulting in the absence of vascularization in 
any scaffold-based engineered tissue (Boland et. al. 2003). 
For these reasons and more, other scaffold- free tissue 
engineering options have been explored.   
 Bioprinting uses 3D printing technology to print 
cells layer-by-layer and create biological materials, and is 
an example of scaffold-free tissue engineering. One of the 
largest roadblocks in the success of scaffold-based tissue 
engineering was the inability to create vascular structures. 
In 2009, vascular tissue was successfully engineered using 
scaffold-free bioprinting. In this study, a rapid prototyping 
technology was developed which instructed a bioprinter to 
deposit bioink onto biopaper. More specifically, multicellu-
lar tissue spheroids of Chinese hamster ovary cells, human 
skin fibroblast cells, and human umbilical vein smooth 
muscle cells were used as bioink. In addition, agarose rods 
were used to build a template for the tubular vascular 
structure. These materials were placed layer by layer onto 
a biopaper made of collagen gel using a bioprinter that 
was designed with two printing heads. This allowed the 
simultaneous placement of the multicellular spheroids as 
well as the agarose rods. The use of the agarose rods as a 
template allowed the diameter of the tubular structure, 
the wall thickness, and the branching pattern of the vascu-
lature to be accurately controlled. Once the spheroids 
were all deposited in the correct locations, their fusion was 
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monitored. It took 5-7 days for fusion to be complete and 
the tubular vasculature to be fully formed. The fused prod-
ucts were placed in a bioreactor for further maturation. 
Maturation is important before implantation because 
there are many cellular mechanical properties that need to 
be developed. 
 Once it was determined that the bioprinting was 
successful, the study was repeated with some variations. In 
the first, multicellular cylinders are used instead of sphe-
roids. The bioprinter attachments had to be adjusted, but 
the printing of cylindrical units allowed for computer auto-
mation. In another, double-layered vascular tubes were 
created using both HUVSMC and HCF cylinders in specific 
patterns. Spheroids of different sizes were tested, and vari-
ous bioprinter attachments were experimented with. 
 This study proved the effectiveness of scaffold-free 
tissue engineering using bioprinting. High cell density was 
achieved because the engineering materials only consisted 
of cells. In addition, when multicellular cylinders were 
used, fusion occurred within 2-4 days and uniform tubes 
were formed with minimal cell damage. There are some 
limitations though with methods and materials used in the 
study. For example, the thickness of the vascular wall pre-
vents all cells from access to the diffused nutrients and 
oxygen. Therefore, apoptotic cells were observed in no 
apparent pattern throughout the final construct. In order 
to avoid this issue, microvasculature is necessary, but even 
with the advances that have been made, there is no visible 
solution as of yet. If it were possible to print thinner vascu-
lar walls, the cells would avoid apoptosis and cell viability 
would be increased. But the wall thickness and tube diam-
eter of the vascular tissue is limited by micropipette size 
and resolution restrictions. Another issue that arose was 
the removal of the agarose rods. In the current study, the 
rods are removed manually. But this limits the geometry of 
the vascular branch necessitating open ends, and becomes 
more difficult to accomplish with more complex geometric 
constructs. The authors suggest thermosensitive or photo-
sensitive gels as an alternative to agarose in order to elimi-
nate this problem. This study demonstrated the ad-
vantages of scaffold-free tissue engineering over scaffold-
ing, but in the process came up with a host of limitations 
specific to the methods used (Norotte et. al.,  2009). 
Successful Bioprinting of Mammalian Cells 
 One of the major hurdles to overcome in the study 
of tissue engineering is the complete interaction of the 
many cell types needed to fabricate complex tissue or or-
gans. These cells need to be placed in very specific loca-
tions and fuse together forming a functional biological con-
struct. A study demonstrated that mammalian cells can be 
successfully printed using a modified HP inkjet thermal 
printer and retain their functionality. Although bacterial 
cells had previously been printed successfully, the heat and 
pressure that are part and parcel of thermal printing had 
the potential to damage mammalian cells which are more 
sensitive than their bacterial counterparts. With the use of 
a modified HP 550C as bioprinter, soy agar and collagen 
hydrogels as biopaper and Chinese Hamster Ovary cells 
and embryonic rat motoneurons as bioink, viable mamma-
lian cells were printed. 
 Suspended cells were printed in circular patterns 
onto the hydrogel-coated coverslips. Over the next few 
days the cells were studied under epiflourescent micro-
scopes to determine whether or not the thermal printing 
process proved lethal. Green fluorescent light was ob-
served, leading to the conclusion that the cells survived the 
stresses of printing. In addition to monitoring cell growth 
with advanced microscopy, an assay was performed to 
measure the percentage of lysed cells. When a cell under-
goes lysis, an enzyme called LDH is released. By determin-
ing the amount of LDH present, the percentage of cell lysis 
was measured to be less than 10% in all cases, and 3.3%
±3.7% on average. The reason the cells were not damaged 
and killed by the temperatures near 300° C is because the 
heat does not have time to spread through the cells sus-
pended in liquid. The droplets of bioink are printed so 
quickly that most of the cells do not experience a substan-
tial rise in temperature (Xu et. al., 2005). 
Inkjet Printing of Neurons Results in Viable Cell  
Structures 
 A lot of research is being devoted to the genera-
tion of nervous tissue because most neuronal cells have 
very low rates of regeneration. In the previously recounted 
study it was demonstrated that over 90% of cells can go 




properties of those printed cells were examined in an inno-
vative study. Although cell viability has previously been 
proven, this study aimed to determine whether cells that 
have been printed can retain their function. The cells in-
volved in this study were rat primary hippocampal and cor-
tical neurons. Although the temperature and other stress-
es of bioprinting largely do not affect printed cells, they 
may affect the electrophysiological properties of neurons. 
An example of a neural property that might be affected is 
the ability to fire action potentials. 
 A modified HP 550 inkjet printer was used to de-
posit the bioink in a circular pattern onto a collagen gel 
based biopaper. Axon and dendrite regeneration were 
demonstrated using immunostaining using MAP-2 as a 
dendritic marker and NF150 as an axonal filament marker. 
Immunostaining showed that the hippocampal and cortical 
neurons had regenerated all axonal and dendritic process-
es. This had been a concern- that the neurons would lose 
their neuronal phenotypes through the printing process. 
That would be very worrisome because the neurons could 
turn into other cells types like glial cells or cancer cells 
after losing their own cell phenotypes. After two weeks, 
the patch-clamp method was used to measure various 
electrophysiological properties including firing thresholds, 
repetitive firing, and after-hyperpolarization. This is an 
electrophysiological technique that studies multiple ion 
channels in excitable cells such as neurons and records 
their voltage currents. Results showed that the mem-
branes of the cortical neurons contained mature voltage-
gated potassium and sodium channels. In addition, no sig-
nificant differences in electrophysiological activity were 
observed between regular hippocampal neurons and those 
that had been printed. Both cortical and hippocampal neu-
rons were found capable of initiating action potentials. As 
is the case with mammalian cells, the retention of func-
tionality after printing is due to the incredibly fast 
timeframe exhibited in thermal inkjet printing. The neu-
rons were also not vulnerable to the shear and pressure of 
the inkjet printing because they cells had been trypsinized. 
That meant that the printed cells had no internal architec-
ture and were not damaged by the shear stresses. Had the 
cells been affected they would have experienced either 
apoptosis or heat shock. Because the cells retained their 
function, it can be inferred that neither effect took place. 
Once these tests were administered on the single-layer 
neuron structures, 3D structures were printed. Fibrin gel 
was formed by printing thrombin droplets over layers of 
fibrinogen. NT2 neurons were printed layer-by-layer with 
the fibrin gel. High resolution SEM was used to examine 
the fibrin scaffold, and determined that it was well suited 
to serve as a scaffold for neurons because of its porous 
microstructure, allowing nutrients and oxygen to be deliv-
ered easily to the neurons within the scaffold. Another ad-
vantage that fibrin has over other hydrogel is the strong 
affinity of neurons for fibrin. Because the neurons attach 
strongly onto the fibrin scaffold, cell signaling is kept intact 
and cell functions are carried out. This study examined 
both 2D and 3D printing of neurons and demonstrated 
neuron viability and retention of cell phenotype and elec-
trophysiological function (Xu et. al., 2006). 
Laser-Assisted Bioprinting of Skin Substitutes 
 Once a person experiences an extensive burn inju-
ry, there are a limited number of options for their rehabili-
tation. If the wound is large, skin grafts cannot cover the 
entire area, due to their finite nature. There are a number 
of clinically approved skin substitutes like Integra and 
Matriderm which serve as either permanent or temporary 
wound coverage. These options leave scarring, discoloring, 
absence of hair follicles and can lead to other damaging 
side effects as well. Therefore, tissue engineering of skin 
substitutes is under high demand. Many challenges stand 
in the way of fabricating skin, due in part to the many cell 
types which need to be arranged in a very specific pattern. 
Furthermore, the functions of the engineered skin are 
greatly affected by the microenvironment of each cell type. 
A recent study demonstrated that a skin substitute could 
be created using laser-assisted bioprinting. The different 
cells types involved in the engineering process included 
human osteosarcoma cells, mouth endothelial cells, hu-
man osteoprogenitor cells, rodent olfactory ensheathing 
cells, human endothelial cells and human adipose derived 
mesenchymal stem cells. The cells were mixed with a colla-
gen hydrogel before printing. 
 Twenty layers each of fibroblasts and keratino-
cytes were printed on top of a layer of Matriderm using 
laser printing technology. The Matriderm layer was im-
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monitored. It took 5-7 days for fusion to be complete and 
the tubular vasculature to be fully formed. The fused prod-
ucts were placed in a bioreactor for further maturation. 
Maturation is important before implantation because 
there are many cellular mechanical properties that need to 
be developed. 
 Once it was determined that the bioprinting was 
successful, the study was repeated with some variations. In 
the first, multicellular cylinders are used instead of sphe-
roids. The bioprinter attachments had to be adjusted, but 
the printing of cylindrical units allowed for computer auto-
mation. In another, double-layered vascular tubes were 
created using both HUVSMC and HCF cylinders in specific 
patterns. Spheroids of different sizes were tested, and vari-
ous bioprinter attachments were experimented with. 
 This study proved the effectiveness of scaffold-free 
tissue engineering using bioprinting. High cell density was 
achieved because the engineering materials only consisted 
of cells. In addition, when multicellular cylinders were 
used, fusion occurred within 2-4 days and uniform tubes 
were formed with minimal cell damage. There are some 
limitations though with methods and materials used in the 
study. For example, the thickness of the vascular wall pre-
vents all cells from access to the diffused nutrients and 
oxygen. Therefore, apoptotic cells were observed in no 
apparent pattern throughout the final construct. In order 
to avoid this issue, microvasculature is necessary, but even 
with the advances that have been made, there is no visible 
solution as of yet. If it were possible to print thinner vascu-
lar walls, the cells would avoid apoptosis and cell viability 
would be increased. But the wall thickness and tube diam-
eter of the vascular tissue is limited by micropipette size 
and resolution restrictions. Another issue that arose was 
the removal of the agarose rods. In the current study, the 
rods are removed manually. But this limits the geometry of 
the vascular branch necessitating open ends, and becomes 
more difficult to accomplish with more complex geometric 
constructs. The authors suggest thermosensitive or photo-
sensitive gels as an alternative to agarose in order to elimi-
nate this problem. This study demonstrated the ad-
vantages of scaffold-free tissue engineering over scaffold-
ing, but in the process came up with a host of limitations 
specific to the methods used (Norotte et. al.,  2009). 
Successful Bioprinting of Mammalian Cells 
 One of the major hurdles to overcome in the study 
of tissue engineering is the complete interaction of the 
many cell types needed to fabricate complex tissue or or-
gans. These cells need to be placed in very specific loca-
tions and fuse together forming a functional biological con-
struct. A study demonstrated that mammalian cells can be 
successfully printed using a modified HP inkjet thermal 
printer and retain their functionality. Although bacterial 
cells had previously been printed successfully, the heat and 
pressure that are part and parcel of thermal printing had 
the potential to damage mammalian cells which are more 
sensitive than their bacterial counterparts. With the use of 
a modified HP 550C as bioprinter, soy agar and collagen 
hydrogels as biopaper and Chinese Hamster Ovary cells 
and embryonic rat motoneurons as bioink, viable mamma-
lian cells were printed. 
 Suspended cells were printed in circular patterns 
onto the hydrogel-coated coverslips. Over the next few 
days the cells were studied under epiflourescent micro-
scopes to determine whether or not the thermal printing 
process proved lethal. Green fluorescent light was ob-
served, leading to the conclusion that the cells survived the 
stresses of printing. In addition to monitoring cell growth 
with advanced microscopy, an assay was performed to 
measure the percentage of lysed cells. When a cell under-
goes lysis, an enzyme called LDH is released. By determin-
ing the amount of LDH present, the percentage of cell lysis 
was measured to be less than 10% in all cases, and 3.3%
±3.7% on average. The reason the cells were not damaged 
and killed by the temperatures near 300° C is because the 
heat does not have time to spread through the cells sus-
pended in liquid. The droplets of bioink are printed so 
quickly that most of the cells do not experience a substan-
tial rise in temperature (Xu et. al., 2005). 
Inkjet Printing of Neurons Results in Viable Cell  
Structures 
 A lot of research is being devoted to the genera-
tion of nervous tissue because most neuronal cells have 
very low rates of regeneration. In the previously recounted 
study it was demonstrated that over 90% of cells can go 




properties of those printed cells were examined in an inno-
vative study. Although cell viability has previously been 
proven, this study aimed to determine whether cells that 
have been printed can retain their function. The cells in-
volved in this study were rat primary hippocampal and cor-
tical neurons. Although the temperature and other stress-
es of bioprinting largely do not affect printed cells, they 
may affect the electrophysiological properties of neurons. 
An example of a neural property that might be affected is 
the ability to fire action potentials. 
 A modified HP 550 inkjet printer was used to de-
posit the bioink in a circular pattern onto a collagen gel 
based biopaper. Axon and dendrite regeneration were 
demonstrated using immunostaining using MAP-2 as a 
dendritic marker and NF150 as an axonal filament marker. 
Immunostaining showed that the hippocampal and cortical 
neurons had regenerated all axonal and dendritic process-
es. This had been a concern- that the neurons would lose 
their neuronal phenotypes through the printing process. 
That would be very worrisome because the neurons could 
turn into other cells types like glial cells or cancer cells 
after losing their own cell phenotypes. After two weeks, 
the patch-clamp method was used to measure various 
electrophysiological properties including firing thresholds, 
repetitive firing, and after-hyperpolarization. This is an 
electrophysiological technique that studies multiple ion 
channels in excitable cells such as neurons and records 
their voltage currents. Results showed that the mem-
branes of the cortical neurons contained mature voltage-
gated potassium and sodium channels. In addition, no sig-
nificant differences in electrophysiological activity were 
observed between regular hippocampal neurons and those 
that had been printed. Both cortical and hippocampal neu-
rons were found capable of initiating action potentials. As 
is the case with mammalian cells, the retention of func-
tionality after printing is due to the incredibly fast 
timeframe exhibited in thermal inkjet printing. The neu-
rons were also not vulnerable to the shear and pressure of 
the inkjet printing because they cells had been trypsinized. 
That meant that the printed cells had no internal architec-
ture and were not damaged by the shear stresses. Had the 
cells been affected they would have experienced either 
apoptosis or heat shock. Because the cells retained their 
function, it can be inferred that neither effect took place. 
Once these tests were administered on the single-layer 
neuron structures, 3D structures were printed. Fibrin gel 
was formed by printing thrombin droplets over layers of 
fibrinogen. NT2 neurons were printed layer-by-layer with 
the fibrin gel. High resolution SEM was used to examine 
the fibrin scaffold, and determined that it was well suited 
to serve as a scaffold for neurons because of its porous 
microstructure, allowing nutrients and oxygen to be deliv-
ered easily to the neurons within the scaffold. Another ad-
vantage that fibrin has over other hydrogel is the strong 
affinity of neurons for fibrin. Because the neurons attach 
strongly onto the fibrin scaffold, cell signaling is kept intact 
and cell functions are carried out. This study examined 
both 2D and 3D printing of neurons and demonstrated 
neuron viability and retention of cell phenotype and elec-
trophysiological function (Xu et. al., 2006). 
Laser-Assisted Bioprinting of Skin Substitutes 
 Once a person experiences an extensive burn inju-
ry, there are a limited number of options for their rehabili-
tation. If the wound is large, skin grafts cannot cover the 
entire area, due to their finite nature. There are a number 
of clinically approved skin substitutes like Integra and 
Matriderm which serve as either permanent or temporary 
wound coverage. These options leave scarring, discoloring, 
absence of hair follicles and can lead to other damaging 
side effects as well. Therefore, tissue engineering of skin 
substitutes is under high demand. Many challenges stand 
in the way of fabricating skin, due in part to the many cell 
types which need to be arranged in a very specific pattern. 
Furthermore, the functions of the engineered skin are 
greatly affected by the microenvironment of each cell type. 
A recent study demonstrated that a skin substitute could 
be created using laser-assisted bioprinting. The different 
cells types involved in the engineering process included 
human osteosarcoma cells, mouth endothelial cells, hu-
man osteoprogenitor cells, rodent olfactory ensheathing 
cells, human endothelial cells and human adipose derived 
mesenchymal stem cells. The cells were mixed with a colla-
gen hydrogel before printing. 
 Twenty layers each of fibroblasts and keratino-
cytes were printed on top of a layer of Matriderm using 
laser printing technology. The Matriderm layer was im-
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portant because it helps keep the printed skin constructs 
more stable during transplantation. The 3D skin constructs 
were incubated overnight, and then pieces were punched 
out and transplanted into the skin fold chambers of 12 
mice that exhibited full-thickness wounds. In addition to 
this in vivo approach, the 3D constructs were cultivated in 
vitro as a control group. 
 The mice reacted well to the treatment, showing 
no discomfort or inflammation as a result of the transplan-
tation procedure. In addition, after 11 days, the transplant-
ed skin substitute and the surrounding mouse skin had 
fused completely together. There were no sharp lines de-
lineating the border between real and substitute skin, and 
while the substitute skin was shiny at first it became matt 
as time passed. The keratinocytes and fibroblasts had been 
labeled before printing and implantation so that extensive 
tests could be administered even after transplantation. 
Results of these assays showed that the keratinocytes 
formed a stratified layer of tissue on top of the fibroblasts 
and Matriderm much like an epidermis. Although this epi-
dermis was thinner than the natural mouse epidermis, 
after 11 days the two completely fused together. The thin-
ner epidermis in the substituted skin might pose a problem 
because it is less stable than the epidermis of natural skin, 
but the methods of the study can be modified in the future 
to amend that flaw. In this study it was also shown that 
fibroblasts formed a multi-layer sheet of tissue. Some re-
mained above the Matriderm where they had been printed 
and secreted collagen, while others spread through the 
Matriderm layer. 
 A skin construct that is incredibly similar to native 
skin was successfully printed using LaBP. The cells survived 
the bioprinting process without their phenotype being im-
pacted in any way. One major advantage of the bioprinted 
skin substitutes is that blood vessel formation was ob-
served in the skin constructs. Fast vascularization is imper-
ative so that the cells can receive oxygen and eliminate cell 
waste. Complete vascularization was not achieved, but the 
authors assume that the issue was due to the time con-
straints of the study and that complete vascularization of 
the skin substitutes needs more time to be carried out. 
Despite this setback, this study demonstrated that blood 
vessels branched from the wound site and spread through 
the skin substitute very quickly, which is of the highest pri-
ority among engineered tissue (Michael et. al., 2013). 
 
 
Effective Microvasculature Fabrication Using Inkjet  
Bioprinting 
 In the previously recounted study, a skin substitute 
was fabricated using laser-assisted bioprinting technology. 
Despite the fact that skin is a very complex organ, it is one 
of the few successfully engineered tissue constructs. Be-
cause skin is relatively thin, vascular tissue can either grow 
from the native skin and migrate through the skin con-
struct, or nutrients and wastes can diffuse through the en-
gineered tissue to and from the vasculature of the host’s 
native tissue. Vasculature is one of the main challenges in 
tissue engineering because cells cannot survive without 
pathways for nutrients to be delivered and cellular waste 
to be eliminated. Another study detailed the use of inkjet 
bioprinters in the creation of human microvasculature. An 
HP 500 thermal inkjet printer was modified so that human 
microvascular endothelial cells and fibrin could be printed 
simultaneously. HMVEC are the only cells with the ability 
to form capillaries, and also have the unique property of 
adjusting their number and structure based on their micro-
environments. Fibrin can be used in many ways- fibrin can 
be produced by the blood and plays a part in natural 
wound healing, fibrin gels are used as adhesives during 
surgery, fibrin glue can be used as a skin graft, and fibrin 
has been utilized extensively in tissue engineering. In this 
study, fibrin gel was used as a biopaper substrate for the 
HMVEC to be printed onto, and it was polymerized by 
combining varying concentrations of fibrinogen, thrombin 
and calcium. After the printed construct was incubated, a 
scanning electron microscope was used to facilitate the 
examination of the microstructure of the fibrin. Its me-
chanical properties were tested as well using an MTS elec-
tromechanical testing system. Results showed that the fi-
brin gel scaffold underwent only minor deformations as a 
consequence of the bioprinting process. A Live/Dead Via-
bility/Cytotoxicity Kit was used to stain the HMVEC so that 
the formation of microvasculature could be observed and 
analyzed. After only 7 days, proliferation of the cells was 




21 days. The microvasculature exhibited tubular structures 
which is consistent with the channels and tubes usually 
formed by endothelial cells. This demonstrates that ther-
mal inkjet printers can be used to successfully fabricate 
human microvasculature which is fully functional (Cui, Bo-
land, 2009). 
Challenges in the Way of Organ Printing 
 Before any of the technology and methods pro-
posed above can be implemented, one of the first steps to 
be done in organ printing is creating an organ blueprint. It 
is a computer-aided design that uses computer software to 
create a three-dimensional model. The software program 
then directs the bioprinter to deposit each biocomponent 
layer-by-layer. The challenge with organ blueprints is that 
they need to account for the post-printing processing that 
the 3D printed construct will undergo as a result of tissue 
fusion and maturation (Mironov et. al., 2008). 
 Many studies have experimented with various bi-
oprinters, biopapers, and bioink in order to optimize the 
bioprinting process. In addition to further improvements in 
these areas, bioreactors are an important component of 
the bioprinting process. Bioreactors are commonly used in 
tissue engineering but there are specific properties that 
bioprinting necessitates. A bioreactor enables the post-
processing step, probably bioprinting’s most crucial step, 
to occur. After a tissue construct or organ is printed, the 
cells need time to fuse together and assemble a functional 
3D construct. The bioreactor needs to be integrated close-
ly enough with the bioprinter that the fragile printed con-
structs can be placed in its sterile conditions without incur-
ring damage. The bioreactor also needs to allow perfusion 
of the vasculature in the printed construct. It takes time 
though before the vascular system is developed so the bio-
reactor also needs to provide a temporary irrigation sys-
tem. This can be achieved using porous needles with pres-
sure controlled dripper systems that can provide the wet 
environment that the tissue needs for its development. 
When the vasculature is sufficiently developed, the irriga-
tion is terminated and perfusion of the vascular tree com-
mences (Mironov et. al., 2011). 
 The last step in the bioprinting process is post-
processing, and as was previously mentioned, it is probably 
the most crucial one. That is why biomonitoring proce-
dures must be created and applied. It is important to moni-
tor the tissue maturation and the kinetics of tissue self-
assembly. In addition, maturogens that aid and accelerate 
post-processing and tissue maturation are necessary. Ma-
turogens are biological, chemical, or physical factors and 
procedures that effectively ensure that the printed cell 
constructs become a fully-functional three-dimensional 
organ (Mironov et. al., 2008). 
The Feasability of Organ Printing 
 There are three major phases in the organ printing 
procedure: preprocessing, processing, and post-
processing. Preprocessing involves the development of an 
organ blueprint or alternate CAD. Processing refers to the 
actual printing of cells onto a substrate, forming a 3D con-
struct. Post-processing concerns the fusion of the cells, the 
perfusion of the vasculature and tissue maturation. Many 
studies have been recounted throughout this paper which 
address every aspect of the organ printing process. Obvi-
ously much advancement must be made in every aspect of 
bioprinting technology before it can be applied to organ 
printing, but the feasibility of using bioprinting technolo-
gies to print an organ is strongly indicated by the ground-
breaking scientific research that has inundated this field in 
the recent years (Mironov et. al., 2003). 
Conclusion 
 After reviewing the scientific data related to bi-
oprinting, it is safe to say that there is currently no way to 
successfully print a fully functional organ. But that is not to 
say that bioprinting isn’t a viable method for organ regen-
eration. Bioprinting is a science that is less than two dec-
ades old and as a result, the technology and mechanisms 
are not advanced enough at this stage in time. The re-
search that has been reviewed in this paper demonstrates 
though that every aspect of the organ printing process is 
being tackled and is a work-in-progress. 
 So much success has been achieved in so few 
years and there is definitely a long way to go. Each study 
brings forth an important piece of the enormous puzzle 
that is bioprinting. There are obviously many revisions to 
the experiments and advancements to the technology that 
must be undergone before organ printing can make the 
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portant because it helps keep the printed skin constructs 
more stable during transplantation. The 3D skin constructs 
were incubated overnight, and then pieces were punched 
out and transplanted into the skin fold chambers of 12 
mice that exhibited full-thickness wounds. In addition to 
this in vivo approach, the 3D constructs were cultivated in 
vitro as a control group. 
 The mice reacted well to the treatment, showing 
no discomfort or inflammation as a result of the transplan-
tation procedure. In addition, after 11 days, the transplant-
ed skin substitute and the surrounding mouse skin had 
fused completely together. There were no sharp lines de-
lineating the border between real and substitute skin, and 
while the substitute skin was shiny at first it became matt 
as time passed. The keratinocytes and fibroblasts had been 
labeled before printing and implantation so that extensive 
tests could be administered even after transplantation. 
Results of these assays showed that the keratinocytes 
formed a stratified layer of tissue on top of the fibroblasts 
and Matriderm much like an epidermis. Although this epi-
dermis was thinner than the natural mouse epidermis, 
after 11 days the two completely fused together. The thin-
ner epidermis in the substituted skin might pose a problem 
because it is less stable than the epidermis of natural skin, 
but the methods of the study can be modified in the future 
to amend that flaw. In this study it was also shown that 
fibroblasts formed a multi-layer sheet of tissue. Some re-
mained above the Matriderm where they had been printed 
and secreted collagen, while others spread through the 
Matriderm layer. 
 A skin construct that is incredibly similar to native 
skin was successfully printed using LaBP. The cells survived 
the bioprinting process without their phenotype being im-
pacted in any way. One major advantage of the bioprinted 
skin substitutes is that blood vessel formation was ob-
served in the skin constructs. Fast vascularization is imper-
ative so that the cells can receive oxygen and eliminate cell 
waste. Complete vascularization was not achieved, but the 
authors assume that the issue was due to the time con-
straints of the study and that complete vascularization of 
the skin substitutes needs more time to be carried out. 
Despite this setback, this study demonstrated that blood 
vessels branched from the wound site and spread through 
the skin substitute very quickly, which is of the highest pri-
ority among engineered tissue (Michael et. al., 2013). 
 
 
Effective Microvasculature Fabrication Using Inkjet  
Bioprinting 
 In the previously recounted study, a skin substitute 
was fabricated using laser-assisted bioprinting technology. 
Despite the fact that skin is a very complex organ, it is one 
of the few successfully engineered tissue constructs. Be-
cause skin is relatively thin, vascular tissue can either grow 
from the native skin and migrate through the skin con-
struct, or nutrients and wastes can diffuse through the en-
gineered tissue to and from the vasculature of the host’s 
native tissue. Vasculature is one of the main challenges in 
tissue engineering because cells cannot survive without 
pathways for nutrients to be delivered and cellular waste 
to be eliminated. Another study detailed the use of inkjet 
bioprinters in the creation of human microvasculature. An 
HP 500 thermal inkjet printer was modified so that human 
microvascular endothelial cells and fibrin could be printed 
simultaneously. HMVEC are the only cells with the ability 
to form capillaries, and also have the unique property of 
adjusting their number and structure based on their micro-
environments. Fibrin can be used in many ways- fibrin can 
be produced by the blood and plays a part in natural 
wound healing, fibrin gels are used as adhesives during 
surgery, fibrin glue can be used as a skin graft, and fibrin 
has been utilized extensively in tissue engineering. In this 
study, fibrin gel was used as a biopaper substrate for the 
HMVEC to be printed onto, and it was polymerized by 
combining varying concentrations of fibrinogen, thrombin 
and calcium. After the printed construct was incubated, a 
scanning electron microscope was used to facilitate the 
examination of the microstructure of the fibrin. Its me-
chanical properties were tested as well using an MTS elec-
tromechanical testing system. Results showed that the fi-
brin gel scaffold underwent only minor deformations as a 
consequence of the bioprinting process. A Live/Dead Via-
bility/Cytotoxicity Kit was used to stain the HMVEC so that 
the formation of microvasculature could be observed and 
analyzed. After only 7 days, proliferation of the cells was 




21 days. The microvasculature exhibited tubular structures 
which is consistent with the channels and tubes usually 
formed by endothelial cells. This demonstrates that ther-
mal inkjet printers can be used to successfully fabricate 
human microvasculature which is fully functional (Cui, Bo-
land, 2009). 
Challenges in the Way of Organ Printing 
 Before any of the technology and methods pro-
posed above can be implemented, one of the first steps to 
be done in organ printing is creating an organ blueprint. It 
is a computer-aided design that uses computer software to 
create a three-dimensional model. The software program 
then directs the bioprinter to deposit each biocomponent 
layer-by-layer. The challenge with organ blueprints is that 
they need to account for the post-printing processing that 
the 3D printed construct will undergo as a result of tissue 
fusion and maturation (Mironov et. al., 2008). 
 Many studies have experimented with various bi-
oprinters, biopapers, and bioink in order to optimize the 
bioprinting process. In addition to further improvements in 
these areas, bioreactors are an important component of 
the bioprinting process. Bioreactors are commonly used in 
tissue engineering but there are specific properties that 
bioprinting necessitates. A bioreactor enables the post-
processing step, probably bioprinting’s most crucial step, 
to occur. After a tissue construct or organ is printed, the 
cells need time to fuse together and assemble a functional 
3D construct. The bioreactor needs to be integrated close-
ly enough with the bioprinter that the fragile printed con-
structs can be placed in its sterile conditions without incur-
ring damage. The bioreactor also needs to allow perfusion 
of the vasculature in the printed construct. It takes time 
though before the vascular system is developed so the bio-
reactor also needs to provide a temporary irrigation sys-
tem. This can be achieved using porous needles with pres-
sure controlled dripper systems that can provide the wet 
environment that the tissue needs for its development. 
When the vasculature is sufficiently developed, the irriga-
tion is terminated and perfusion of the vascular tree com-
mences (Mironov et. al., 2011). 
 The last step in the bioprinting process is post-
processing, and as was previously mentioned, it is probably 
the most crucial one. That is why biomonitoring proce-
dures must be created and applied. It is important to moni-
tor the tissue maturation and the kinetics of tissue self-
assembly. In addition, maturogens that aid and accelerate 
post-processing and tissue maturation are necessary. Ma-
turogens are biological, chemical, or physical factors and 
procedures that effectively ensure that the printed cell 
constructs become a fully-functional three-dimensional 
organ (Mironov et. al., 2008). 
The Feasability of Organ Printing 
 There are three major phases in the organ printing 
procedure: preprocessing, processing, and post-
processing. Preprocessing involves the development of an 
organ blueprint or alternate CAD. Processing refers to the 
actual printing of cells onto a substrate, forming a 3D con-
struct. Post-processing concerns the fusion of the cells, the 
perfusion of the vasculature and tissue maturation. Many 
studies have been recounted throughout this paper which 
address every aspect of the organ printing process. Obvi-
ously much advancement must be made in every aspect of 
bioprinting technology before it can be applied to organ 
printing, but the feasibility of using bioprinting technolo-
gies to print an organ is strongly indicated by the ground-
breaking scientific research that has inundated this field in 
the recent years (Mironov et. al., 2003). 
Conclusion 
 After reviewing the scientific data related to bi-
oprinting, it is safe to say that there is currently no way to 
successfully print a fully functional organ. But that is not to 
say that bioprinting isn’t a viable method for organ regen-
eration. Bioprinting is a science that is less than two dec-
ades old and as a result, the technology and mechanisms 
are not advanced enough at this stage in time. The re-
search that has been reviewed in this paper demonstrates 
though that every aspect of the organ printing process is 
being tackled and is a work-in-progress. 
 So much success has been achieved in so few 
years and there is definitely a long way to go. Each study 
brings forth an important piece of the enormous puzzle 
that is bioprinting. There are obviously many revisions to 
the experiments and advancements to the technology that 
must be undergone before organ printing can make the 
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leap from the lab to industrial-level production. Neverthe-
less, the viability of organ printing is affirmed by the enor-
mous amount of progress and success in the bioprinting 
field. 
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 Brain ischemia is a condition where there is insuffi-
cient blood flow to the brain to meet the metabolic de-
mand.  Focal ischemia occurs when a blood clot blocks a 
cerebral vessel and it reduces blood flow and causes cell 
death to a confined region of the brain.  Global ischemia, 
on the other hand occurs when blood flow to the entire 
brain is drastically reduced and the damage encompasses 
vast areas of brain tissue.  When one suffers from focal 
ischemia and experiences brain cell death in a certain re-
gion, the area surrounding the ischemic core is called the 
peri-infarct cortex.  While this area is compromised, it is 
potentially salvageable, so researchers study the physio-
logic changes that take place there. When ischemia occurs, 
energy hungry neurons stop functioning within seconds 
due to a lack of oxygen and they quickly show signs of 
structural damage.  As the energy dependent processes 
fail, neurons cannot maintain their normal trans-
membrane ionic gradients, leading to cell death, or stroke, 
and the impairment of sensory and motor functioning.   
 Stroke, which affects a large percentage of the 
population, is the cause of a lot of physical and emotional 
suffering for the victims and their families.  This is because 
it causes significant damage to brain tissue and to external 
neuronal connections that are involved in cognitive and 
functional tasks.  While there are currently no pharmaco-
logical agents that can aid in restoring these functions, by 
studying and understanding the mechanisms that underlie 
spontaneous neural plasticity, researchers can identify 
neurobiological signals which can be critical for treatment 
and recovery of post-stroke patients (Wieloch T, Nikolich 
K,2006).  This paper details the various mechanisms of 
brain plasticity and how they occur. 
Materials and Methods 
 The information in this paper was obtained by 
critical analysis of scientific research articles and re-
views.  The articles were found in Touro College’s online 
database and from various online medical journals.  Most 
of the information is based on experiments and research 
done on rats because it is the most feasible way of obtain-
ing vast information about strokes and the brain.  While 
this information may not be completely applicable to the 
human brain, researchers feel that there is a lot of im-
portant information that can be obtained this way. 
Discussion 
Dendritic Spines: 
 Pyramidal neurons have a pyramid shaped body 
and are the most numerous excitatory cell type in the fore-
brain.  Apical dendrites emerge from the apex of the py-
ramidal cell body and have membranous protrusions, 
called spines, which are the recipients of most excitatory 
signals in the brain.  They participate in the transmission 
and integration of these signals and can also help increase 
the number of possible contacts between neu-
Neural Plasticity Following Ischemia 
Shira Brickman 
Abstract 
Neural plasticity refers to the ability of one’s brain to change its structure and/or function in response to changes in be-
havior, environment, and neural processes.  When a person suffers an ischemic brain injury, it often leads to hemisyn-
drome with motor and sensory deficits in the arm, leg, and face of one side.  This article discusses the various ways that 
the existing network can be restructured and neuronal connections can be remodeled after the injury to enable partial 
or complete recovery of motor function. Spontaneous functional recovery after stroke develops through the overlapping 
sequence of events including a phase of axonal growth, spine remodeling and spine activation, and a phase of establish-
ing and consolidating new neuronal networks. 
Shira Brickman graduated with a B.S. in Biology on May 2014 and will be attending SUNY Downstate's Physician Assistant Program.  
